Pfizer PGN 225 (Lyrica 225 mg)
Generic Name: pregabalin
Pill imprint Pfizer PGN 225 has been identified as Lyrica 225 mg.
Lyrica is used in the treatment of neuropathic pain; fibromyalgia; diabetic peripheral neuropathy; neuralgia; postherpetic neuralgia (and more), and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica 225 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- pregabalin
- Imprint:
- Pfizer PGN 225
- Strength:
- 225 mg
- Color:
- Orange & White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Gamma-aminobutyric acid analogs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00071-1019
- Inactive Ingredients:
- lactose monohydrate
corn starch
magnesium silicate
gelatin
titanium dioxide
sodium lauryl sulfate
silicon dioxide
ferric oxide red
shellac
ferrosoferric oxide
propylene glycol
potassium hydroxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0733 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
More about Lyrica (pregabalin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
